LENSAR, Inc. (LNSR) News

LENSAR, Inc. (LNSR): $3.23

0.09 (+2.87%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Filter LNSR News Items

LNSR News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest LNSR News From Around the Web

Below are the latest news stories about LENSAR INC that investors may wish to consider to help them evaluate LNSR as an investment opportunity.

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good morning, and thank you for your participation. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the call over to Cameron Radinovic of Burns McClellan, Mr. Radinovic, please go ahead. Cameron Radinovic : Thank […]

Yahoo | November 12, 2023

LENSAR Reports Third Quarter 2023 Results and Provides Business Update

ORLANDO, Fla., November 09, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2023 and provided an update on key operational initiatives.

Yahoo | November 9, 2023

LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

ORLANDO, Fla., November 02, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the Company’s third quarter 2023 financial results will be released before market open on Thursday, November 9, 2023. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, November 9, 2023 to discuss the financial results and recent corpor

Yahoo | November 2, 2023

A Piece Of The Puzzle Missing From LENSAR, Inc.'s (NASDAQ:LNSR) Share Price

With a price-to-sales (or "P/S") ratio of 0.8x LENSAR, Inc. ( NASDAQ:LNSR ) may be sending very bullish signals at the...

Yahoo | October 11, 2023

Several Insiders Invested In LENSAR Flagging Positive News

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Yahoo | August 18, 2023

LENSAR Reports Second Quarter 2023 Results and Provides Business Update

ORLANDO, Fla., August 09, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2023 and provided an update on key operational initiatives.

Yahoo | August 9, 2023

LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups

ORLANDO, Fla., July 24, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that it has completed the installation of multiple ALLY Systems in five private equity-owned ("PE-owned") ophthalmology groups, including EyeSouth Partners’ network. EyeSouth Partners is one of the largest PE-owned ophthalmic focused, premier networks in the U.S., with 35

Yahoo | July 24, 2023

LENSAR Reports First Quarter 2023 Results and Provides Business Update

ORLANDO, Fla., May 15, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended March 31, 2023 and provided an update on key operational initiatives.

Yahoo | May 15, 2023

LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023

ORLANDO, Fla., May 10, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s first quarter 2023 financial results will be released before market open on Monday, May 15, 2023. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Monday, May 15, 2023 to discuss the financial results and recent corporate high

Yahoo | May 10, 2023

LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript

LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Good morning, and thank you for your participation. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. As a reminder, this conference call will be recorded. I would now like to turn the conference over […]

Yahoo | March 20, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!